Literature DB >> 23634363

Diagnostic tests for Alzheimer disease: FDG-PET imaging is a player in search of a role.

David S Knopman1.   

Abstract

Entities:  

Year:  2012        PMID: 23634363      PMCID: PMC3613199          DOI: 10.1212/CPJ.0b013e31825a7801

Source DB:  PubMed          Journal:  Neurol Clin Pract        ISSN: 2163-0402


× No keyword cloud information.
  5 in total

1.  Comparing predictors of conversion and decline in mild cognitive impairment.

Authors:  S M Landau; D Harvey; C M Madison; E M Reiman; N L Foster; P S Aisen; R C Petersen; L M Shaw; J Q Trojanowski; C R Jack; M W Weiner; W J Jagust
Journal:  Neurology       Date:  2010-06-30       Impact factor: 9.910

2.  Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD.

Authors:  G D Rabinovici; H J Rosen; A Alkalay; J Kornak; A J Furst; N Agarwal; E C Mormino; J P O'Neil; M Janabi; A Karydas; M E Growdon; J Y Jang; E J Huang; S J Dearmond; J Q Trojanowski; L T Grinberg; M L Gorno-Tempini; W W Seeley; B L Miller; W J Jagust
Journal:  Neurology       Date:  2011-11-30       Impact factor: 9.910

3.  Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  D S Knopman; S T DeKosky; J L Cummings; H Chui; J Corey-Bloom; N Relkin; G W Small; B Miller; J C Stevens
Journal:  Neurology       Date:  2001-05-08       Impact factor: 9.910

Review 4.  Effectiveness and safety of 18F-FDG PET in the evaluation of dementia: a review of the recent literature.

Authors:  Nicolaas I Bohnen; David S W Djang; Karl Herholz; Yoshimi Anzai; Satoshi Minoshima
Journal:  J Nucl Med       Date:  2011-12-15       Impact factor: 10.057

5.  FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease.

Authors:  Norman L Foster; Judith L Heidebrink; Christopher M Clark; William J Jagust; Steven E Arnold; Nancy R Barbas; Charles S DeCarli; R Scott Turner; Robert A Koeppe; Roger Higdon; Satoshi Minoshima
Journal:  Brain       Date:  2007-08-18       Impact factor: 13.501

  5 in total
  3 in total

1.  Alzheimer's Disease Biomarkers and Future Decline in Cognitive Normal Older Adults.

Authors:  Julien Dumurgier; Bernard J Hanseeuw; Frances B Hatling; Kelly A Judge; Aaron P Schultz; Jasmeer P Chhatwal; Deborah Blacker; Reisa A Sperling; Keith A Johnson; Bradley T Hyman; Teresa Gómez-Isla
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 2.  Brain imaging of neurovascular dysfunction in Alzheimer's disease.

Authors:  Axel Montagne; Daniel A Nation; Judy Pa; Melanie D Sweeney; Arthur W Toga; Berislav V Zlokovic
Journal:  Acta Neuropathol       Date:  2016-04-01       Impact factor: 17.088

3.  Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and 18F-FDG-PET imaging.

Authors:  Julie Ottoy; Ellis Niemantsverdriet; Jeroen Verhaeghe; Ellen De Roeck; Hanne Struyfs; Charisse Somers; Leonie Wyffels; Sarah Ceyssens; Sara Van Mossevelde; Tobi Van den Bossche; Christine Van Broeckhoven; Annemie Ribbens; Maria Bjerke; Sigrid Stroobants; Sebastiaan Engelborghs; Steven Staelens
Journal:  Neuroimage Clin       Date:  2019-03-13       Impact factor: 4.881

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.